What are the risks and benefits of aldosterone synthetase inhibitors?

Aldosterone synthase inhibitors like baxdrostat and lorundrostat effectively reduce blood pressure in resistant hypertension but carry risks of hyperkalemia and other adverse events, warranting careful patient monitoring.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-02
DOI
https://doi.org/10.5281/zenodo.23892792
Primary Topic
Hormonal Regulation and Hypertension
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What are the risks and benefits of aldosterone synthetase inhibitors?

Tripdatabase
1 links
Zenodo (CERN European Organization for Nuclear Research)
Hormonal Regulation and Hypertension
article

What are the risks and benefits of aldosterone synthetase inhibitors?

Tripdatabase
article en

Abstract

Aldosterone synthase inhibitors like baxdrostat and lorundrostat effectively reduce blood pressure in resistant hypertension but carry risks of hyperkalemia and other adverse events, warranting careful patient monitoring.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 13%
Hormonal Regulation and Hypertension
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What are the risks and benefits of aldosterone synthetase inhibitors? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS